ZYVERSA THERAPEUTICS INC (ZVSA)

US98987D3008 - Common Stock

4.4872  -0.37 (-7.67%)

After market: 4.48 -0.01 (-0.16%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.00
Operating Expenses
14.42M13.83M7.70M11.83M
Research and Development
3.21M5.81M2.12M6.47M
Selling, General, and Administrative Expenses
11.20M8.01M5.57M5.35M
Operating Income
-14.42M-13.83M-7.70M-11.83M
Interest Income/Expense
460.00-1.03M-590.00K-850.00K
Non Recurring Items
-93.33M0.00210.00K0.00
Income Before Taxes
-107.75M-14.87M-8.08M-12.68M
Income Tax
-9.46M-750.00K0.000.00
Net Income
-106.25M-24.14M-8.08M-12.68M
EBITDA
-14.41M-13.82M-7.69M-11.82M
 
Per Share Data
EPS Diluted Total Ops
-1.09K-2.62-0.88-1.38
 
Statistics

All data in USD

Charts